Compare ELE & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELE | INVA |
|---|---|---|
| Founded | N/A | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2004 |
| Metric | ELE | INVA |
|---|---|---|
| Price | $19.22 | $21.80 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $36.80 |
| AVG Volume (30 Days) | 417.9K | ★ 701.7K |
| Earning Date | 03-30-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 145.82 | 53.96 |
| EPS | 0.21 | ★ 1.52 |
| Revenue | $33,115,000.00 | ★ $388,521,000.00 |
| Revenue This Year | $146.47 | $13.23 |
| Revenue Next Year | $57.23 | $8.58 |
| P/E Ratio | $229.19 | ★ $14.15 |
| Revenue Growth | ★ 124.30 | 10.14 |
| 52 Week Low | $7.80 | $16.52 |
| 52 Week High | $26.96 | $22.76 |
| Indicator | ELE | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 75.96 |
| Support Level | $18.30 | $19.58 |
| Resistance Level | $22.09 | $19.90 |
| Average True Range (ATR) | 2.03 | 0.50 |
| MACD | -0.34 | 0.27 |
| Stochastic Oscillator | 9.01 | 96.39 |
Elemental Royalty Corp is engaged in exploration discovery, royalty generation, royalty acquisition, and strategic investments.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.